BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Allergy to pollen
,
Hypothalamus
,
Biofuel
,
Doxorubicin
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pd0325901
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SERPINA3
CRIP1
RBP4
DUSP6
XIST
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
regulation of nitrogen compound metabolic process
organic cyclic compound binding
heterocyclic compound binding
organic cyclic compound metabolic process
cell differentiation
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Investigations on the role of Blimp1 in pluripotency and reprogramming
iPSC gene expression in response to culture with a small molecule inhibitor cocktail
Tracing the conversion process for primordial germ cells to pluripotent stem cells
Apollon knockdown in a melanoma cell line treated with fotemustine, PLX4720 or PD0325901
Rapamycin and PD0325901 treatment in a metastatic prostate cancer model
Explore Curated Studies Results
Literature
Most Relevant Literature
PD0325901, an ERK inhibitor, attenuates RANKL-induced osteoclast formation and mitigates cartilage i…
MEK inhibitor PD0325901 significantly boosts ssODN-mediated HDR efficiency in porcine fetal fibrobla…
Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901.
Modulation of spine fusion with BMP-2, MEK inhibitor (PD0325901), and zoledronic acid in a murine mo…
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ